August 30, 2016 10:17 AM ET

Biotechnology

Company Overview of Anacor Pharmaceuticals, Inc.

Company Overview

Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. It markets KERYDIN (tavaborole) topical solution for the treatment of onychomycosis of the toenails. The company’s lead product candidate is crisaborole topical ointment, 2%, anti-inflammatory phosphodiesterase-4 inhibitor, which is in Phase III clinical trials for the treatment of mild-to-moderate atopic dermatitis and psoriasis. It is also developing AN3365, an antibiotic product candidate for the treatment of infections caused by Gram-negative bacteria. The company has collaboration agreements with t...

1020 East Meadow Circle

Palo Alto, CA 94303

United States

Founded in 2000

110 Employees

Phone:

650-543-7500

Fax:

650-543-7660

Key Executives for Anacor Pharmaceuticals, Inc.

Chief Financial Officer and Executive Vice President
Age: 49
Executive Vice President, General Counsel and Secretary
Age: 40
Chief Medical Officer and Senior Vice President of Clinical Development
Age: 46
Chief Commercial Officer and Executive Vice President
Age: 57
Vice President, Secretary and Director
Compensation as of Fiscal Year 2016.

Anacor Pharmaceuticals, Inc. Key Developments

Anacor Pharmaceuticals Files Form 15

Anacor Pharmaceuticals, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common Stock, par value $0.001 per share under the Securities Exchange Act of 1934, as amended.

Anacor Pharmaceuticals, Inc.(NasdaqGM:ANAC) dropped from NASDAQ Biotechnology Index

Anacor Pharmaceuticals, Inc. has been removed from NASDAQ Biotech Index.

Anacor Pharmaceuticals, Inc.(NasdaqGM:ANAC) dropped from NASDAQ Composite Index

Anacor Pharmaceuticals, Inc. has been removed from Nasdaq Composite Index.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 16, 2016
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Anacor Pharmaceuticals, Inc., please visit www.anacor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.